Outcome of Board Meeting

August 10, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Outcome of Board Meeting Ref.: Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulation 30 & 51 read with Part A of Schedule III and other applicable provisions of the Listing Regulations, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. Monday, August 10, 2026, has inter alia considered and approved: i. the appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as an Additional Director, designated as a Non-Executive Independent Director of the Company, with effect from August 10, 2026, based on the recommendation of the Nomination and Remuneration Committee. ii. the Postal Ballot Notice for seeking approval of the members of the Company for the appointment of Mr. Anish Vanraj Bafna, as a Non-Executive Independent Director, for a term of 5 (five) consecutive years. The Postal Ballot Notice will be circulated to the members of the Company in due course. Further, declaration pursuant to BSE Circular No. LIST/COMP/14/2018-19 dated June 20, 2018, and NSE Circular No. NSE/ CML/2018/24 dated June 20, 2018 has been obtained that Mr. Anish Vanraj Bafna is not debarred from holding office of a Director by virtue of any order passed by the Securities and Exchange Board of India (“SEBI”) or any other such authority. The detailed disclosure required pursuant to the applicable provisions of the Listing Regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026 (“SEBI Master Circular”) is enclosed as Annexure I. The Board Meeting commenced at 03:30 p.m. (IST) and concluded at 03:45 p.m. (IST). You are requested to kindly take the above information on your records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a Annexure-I The detailed disclosure required pursuant to the applicable provisions of the Listing Regulations and SEBI Master Circular: Sr. Particulars Details 1. Name Mr. Anish Vanraj Bafna (DIN: 02925792) 2. Reason for change viz. appointment, Appointed as an Additional Director in the category of Non-Executive, re-appointment, resignation, Independent Director. removal, death or otherwise 3. Date of appointment/re- Appointment for a term of 5 (five) consecutive years effective from appointment/cessation (as August 10, 2026, subject to approval of members of the Company. applicable) & term of appointment/re-appointment; 4. Brief profile (in case of Mr. Anish Vanraj Bafna has over 30 years of experience in the appointment) healthcare and medical devices sector, with significant experience in managing global healthcare businesses and operations across multiple geographies. Mr. Bafna previously served as the Chief Executive Officer and Managing Director of Healthium Medtech Limited (“Healthium”) for over eight years, where he was instrumental in driving the company's growth, global expansion and transformation. He is currently serving as the Non-Executive Chairman of Healthium. Prior to his association with Healthium, Mr. Bafna served as President – Japan at Baxter International. He had also served as Regional Head – Emerging Asia at Baxter International, Singapore, where he was responsible for overseeing operations across India and Southeast Asia. Over the course of his career, Mr. Bafna has worked across Vietnam, Indonesia, Malaysia, Singapore, Japan and India, gaining extensive international experience in healthcare business management, strategy development and operational excellence. Mr. Bafna holds a Bachelor’s Degree in Science (Chemistry) from St. Xavier’s, Ahmedabad, and a Post Graduate Diploma in Management (PGDM) from IMDR, Pune. 5. Disclosure of relationships between Mr. Bafna is not related to any Promoter, Director or Key Managerial directors Personnel of the Company and does not have any inter se relationship with any of the existing Director of the Company. He satisfies the criteria of Independence prescribed under the provisions of the Companies Act, 2013 and Listing Regulations.